Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review

The new drugs delamanid and bedaquiline are increasingly used to treat multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB). As evidence is lacking, the World Health Organization recommends their use under specific conditions in adults, delamanid only being recommended in...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Thorac Dis
मुख्य लेखकों: D’Ambrosio, Lia, Centis, Rosella, Tiberi, Simon, Tadolini, Marina, Dalcolmo, Margareth, Rendon, Adrian, Esposito, Susanna, Migliori, Giovanni Battista
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: AME Publishing Company 2017
विषय:
Review Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5542985/
https://ncbi.nlm.nih.gov/pubmed/28840010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.06.16
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन